| 2016-12-22 07:03:02|
RAD 07:03 12/22 12/22/16
Rite Aid reports Q3 adjusted EPS 2c, consensus 4c
Reports Q3 revenue $8.1B, consensus $8.23B. Retail Pharmacy Segment revenues were $6.5B and decreased 3.1% compared to the prior year period primarily as a result of a decrease in same store sales. Revenues in the company's Pharmacy Services Segment were $1.6B and increased 9.7% compared to the prior year period. Same store sales for the quarter decreased 3.4% over the prior year, consisting of a 4.7% decrease in pharmacy sales and a 0.4% decrease in front-end sales. Pharmacy sales included an approximate 182 basis point negative impact from new generic introductions.